BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36557005)

  • 21. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma.
    Kim W; Oe Lim S; Kim JS; Ryu YH; Byeon JY; Kim HJ; Kim YI; Heo JS; Park YM; Jung G
    Clin Cancer Res; 2003 Nov; 9(15):5493-500. PubMed ID: 14654528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
    Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
    J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus infection in black patients with hepatocellular carcinoma in southern Africa.
    Kew MC
    Princess Takamatsu Symp; 1995; 25():33-40. PubMed ID: 8875607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade.
    Ko CC; Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Int J Clin Oncol; 2022 Apr; 27(4):739-748. PubMed ID: 35119581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures.
    Perez S; Lavi-Itzkovitz A; Gidoni M; Domovitz T; Dabour R; Khurana I; Davidovich A; Tobar A; Livoff A; Solomonov E; Maman Y; El-Osta A; Tsai Y; Yu ML; Stemmer SM; Haviv I; Yaari G; Gal-Tanamy M
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):63-81. PubMed ID: 36965814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
    Sun S; Li Y; Han S; Jia H; Li X; Li X
    BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.
    Diao H; Wang L; Huang J; Jiang M; Zhou H; Li X; Chen Q; Jiang Z; Feng H
    J Cell Biochem; 2014 Apr; 115(4):641-50. PubMed ID: 24151232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
    Li S; Hao L; Hu X; Li L
    Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
    Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.